Advaxis, Inc. (ADXS) Buy or Sell Stock Guide

Last Tuesday

Are you looking for the analysis of Advaxis, Inc. (ADXS) stock? Are you wondering what the bulls and the bears say about it?

If so, you came to the right place. In this stock guide, we will share with you 5 reasons to buy and 3 reasons to sell ADXS stock. You’ll get a perspective on what the bulls and the bears say about it.

The analysis below may be also helpful to you if you have any of the following questions about ADXS stock:

  • Is ADXS a buy or a sell?
  • Should I sell or hold ADXS stock today?
  • Is ADXS a good buy / investment?
  • What are ADXS analyst opinions, recommendations and ratings?

Let’s start with the bull case. Here are the reasons to buy ADXS stock:

1. ADXS stock price ($0.33) is close to the 52-week low ($0.19). Perhaps now is a good time to buy? See ADXS price chart.

2. ADXS Price/Book ratio is 0.13, and it’s low compared to its industry peers’ P/B ratios. See ADXS forward Price/Book ratio chart.

3. ADXS Price/Sales ratio is 0.37, and it’s low compared to its industry peers’ P/S ratios. See ADXS forward Price/Sales ratio chart.

4. ADXS average analyst rating is Buy. See ADXS analyst rating chart.

5. ADXS average analyst price target ($5.00) is above its current price ($0.33). See ADXS price target chart.

Now that you understand the bull case, let’s look at the reasons to sell ADXS stock (i.e., the bear case):

1. ADXS quarterly revenue growth was -99.50%, lower than the industry and sector average revenue growth (1.80% and 2.50%, respectively). See ADXS revenue growth chart.

2. ADXS profitability is declining. The YoY profit margin change was -320.45 percentage points. See ADXS profitability chart.

3. ADXS short share of float is 69.70%. The stock is much more frequently shorted than the average industry, sector or S&P 500 stock. See ADXS short share of float chart.

Now let's look at the key statistics for ADXS:

Metrics ADXS
Price $0.37
Average Price Target / Upside $5.00 / 1,241.92%
Average Analyst Rating Buy
Industry Biotechnology
Sector Healthcare
Number of Employees 58
Market Cap $10.27M
Forward P/E Ratio -0.25
Price/Book Ratio 0.47
Revenue (TTM) $22.01M
YoY Quarterly Revenue Growth -99.5%
Profit Margin -113.67%

What are your thoughts on ADXS?

If you liked this analysis, check out Buy or Sell Stock Guides for other stocks.

Follow Us